These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29531265)

  • 1. Modulation of blood-brain barrier function by a heteroduplex oligonucleotide in vivo.
    Kuwahara H; Song J; Shimoura T; Yoshida-Tanaka K; Mizuno T; Mochizuki T; Zeniya S; Li F; Nishina K; Nagata T; Ito S; Kusuhara H; Yokota T
    Sci Rep; 2018 Mar; 8(1):4377. PubMed ID: 29531265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice.
    Miyajima M; Kusuhara H; Fujishima M; Adachi Y; Sugiyama Y
    Drug Metab Dispos; 2011 May; 39(5):814-9. PubMed ID: 21325432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant expression of androgen receptors and their functional regulation of organic anion transporter 3 in rat brain capillary endothelial cells; comparison of gene expression between the blood-brain and -retinal barriers.
    Ohtsuki S; Tomi M; Hata T; Nagai Y; Hori S; Mori S; Hosoya K; Terasaki T
    J Cell Physiol; 2005 Sep; 204(3):896-900. PubMed ID: 15795901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo delivery of small interfering RNA targeting brain capillary endothelial cells.
    Hino T; Yokota T; Ito S; Nishina K; Kang YS; Mori S; Hori S; Kanda T; Terasaki T; Mizusawa H
    Biochem Biophys Res Commun; 2006 Feb; 340(1):263-7. PubMed ID: 16364250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angubindin-1 opens the blood-brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system.
    Zeniya S; Kuwahara H; Daizo K; Watari A; Kondoh M; Yoshida-Tanaka K; Kaburagi H; Asada K; Nagata T; Nagahama M; Yagi K; Yokota T
    J Control Release; 2018 Aug; 283():126-134. PubMed ID: 29753959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system].
    Ohtsuki S
    Yakugaku Zasshi; 2004 Nov; 124(11):791-802. PubMed ID: 15516806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-RNA Heteroduplex Oligonucleotide for Highly Efficient Gene Silencing.
    Hara RI; Yoshioka K; Yokota T
    Methods Mol Biol; 2020; 2176():113-119. PubMed ID: 32865786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein, breast cancer resistance protein, Organic Anion Transporter 3, and Transporting Peptide 1a4 during blood-brain barrier maturation: involvement of Wnt/β-catenin and endothelin-1 signaling.
    Harati R; Benech H; Villégier AS; Mabondzo A
    Mol Pharm; 2013 May; 10(5):1566-80. PubMed ID: 22998451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain.
    Römermann K; Fedrowitz M; Hampel P; Kaczmarek E; Töllner K; Erker T; Sweet DH; Löscher W
    Neuropharmacology; 2017 May; 117():182-194. PubMed ID: 28192112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential delivery of lipid-ligand conjugated DNA/RNA heteroduplex oligonucleotide to ischemic brain in hyperacute stage.
    Li F; Ichinose K; Ishibashi S; Yamamoto S; Iwasawa E; Suzuki M; Yoshida-Tanaka K; Yoshioka K; Nagata T; Hirabayashi H; Mogushi K; Yokota T
    Mol Ther; 2023 Apr; 31(4):1106-1122. PubMed ID: 36694463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly efficient silencing of microRNA by heteroduplex oligonucleotides.
    Yoshioka K; Kunieda T; Asami Y; Guo H; Miyata H; Yoshida-Tanaka K; Sujino Y; Piao W; Kuwahara H; Nishina K; Hara RI; Nagata T; Wada T; Obika S; Yokota T
    Nucleic Acids Res; 2019 Aug; 47(14):7321-7332. PubMed ID: 31214713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain.
    Ohtsuki S; Asaba H; Takanaga H; Deguchi T; Hosoya K; Otagiri M; Terasaki T
    J Neurochem; 2002 Oct; 83(1):57-66. PubMed ID: 12358729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system.
    Ohtsuki S
    Biol Pharm Bull; 2004 Oct; 27(10):1489-96. PubMed ID: 15467183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing.
    Asada K; Sakaue F; Nagata T; Zhang JC; Yoshida-Tanaka K; Abe A; Nawa M; Nishina K; Yokota T
    Nucleic Acids Res; 2021 May; 49(9):4864-4876. PubMed ID: 33928345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4).
    Ose A; Ito M; Kusuhara H; Yamatsugu K; Kanai M; Shibasaki M; Hosokawa M; Schuetz JD; Sugiyama Y
    Drug Metab Dispos; 2009 Feb; 37(2):315-21. PubMed ID: 19029202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing.
    Nishina K; Piao W; Yoshida-Tanaka K; Sujino Y; Nishina T; Yamamoto T; Nitta K; Yoshioka K; Kuwahara H; Yasuhara H; Baba T; Ono F; Miyata K; Miyake K; Seth PP; Low A; Yoshida M; Bennett CF; Kataoka K; Mizusawa H; Obika S; Yokota T
    Nat Commun; 2015 Aug; 6():7969. PubMed ID: 26258894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient in vivo delivery of siRNA into brain capillary endothelial cells along with endogenous lipoprotein.
    Kuwahara H; Nishina K; Yoshida K; Nishina T; Yamamoto M; Saito Y; Piao W; Yoshida M; Mizusawa H; Yokota T
    Mol Ther; 2011 Dec; 19(12):2213-21. PubMed ID: 21915100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats.
    Zhang Z; Tachikawa M; Uchida Y; Terasaki T
    Mol Pharm; 2018 Mar; 15(3):911-922. PubMed ID: 29436232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice.
    Sykes D; Sweet DH; Lowes S; Nigam SK; Pritchard JB; Miller DS
    Am J Physiol Renal Physiol; 2004 May; 286(5):F972-8. PubMed ID: 15075193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective silencing of miR-126 after ischemic stroke by means of intravenous α-tocopherol-conjugated heteroduplex oligonucleotide in mice.
    Suzuki M; Ishibashi S; Iwasawa E; Oguma T; Saito Y; Li F; Otsu S; Ichinose K; Yoshioka K; Nagata T; Yokota T
    Sci Rep; 2021 Jul; 11(1):14237. PubMed ID: 34244578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.